 BD Becton, Dickinson and Company NYSE: BDX, a leading global medical technology company, today reported quarterly revenues of 3.855 billion for the third fiscal quarter ended June 30, 2020. This represents a decrease of 11.4 percent as reported from the prior-year period, or 9.4 percent on a currency-neutral basis. 